Metallodrugs in medicinal inorganic chemistry
KD Mjos, C Orvig - Chemical reviews, 2014 - ACS Publications
Metal ions play important roles in biological processes, 1 and the field of knowledge
concerned with the application of inorganic chemistry to therapy or diagnosis of disease is …
concerned with the application of inorganic chemistry to therapy or diagnosis of disease is …
Matching chelators to radiometals for radiopharmaceuticals
Radiometals comprise many useful radioactive isotopes of various metallic elements. When
properly harnessed, these have valuable emission properties that can be used for …
properly harnessed, these have valuable emission properties that can be used for …
Advancement of metal compounds as therapeutic and diagnostic metallodrugs: Current frontiers and future perspectives
Coordination compounds on account of distinctive features of metal ions that include
variable oxidation states, diverse range of geometries and coordination numbers …
variable oxidation states, diverse range of geometries and coordination numbers …
Prospective of 68Ga-radiopharmaceutical development
I Velikyan - Theranostics, 2013 - pmc.ncbi.nlm.nih.gov
Positron Emission Tomography (PET) experienced accelerated development and has
become an established method for medical research and clinical routine diagnostics on …
become an established method for medical research and clinical routine diagnostics on …
Clinical applications of Gallium-68
Gallium-68 is a positron-emitting radioisotope that is produced from a 68Ge/68Ga generator.
As such it is conveniently used, decoupling radiopharmacies from the need for a cyclotron …
As such it is conveniently used, decoupling radiopharmacies from the need for a cyclotron …
Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application
Currently, different radiometals are in use for imaging and therapy in nuclear medicine:
68Ga and 111In are examples of nuclides for positron emission tomography (PET) and …
68Ga and 111In are examples of nuclides for positron emission tomography (PET) and …
[HTML][HTML] Somatostatin receptor PET ligands-the next generation for clinical practice
Somatostatin receptors (SSTRs) are variably expressed by a variety of malignancies. Using
radiolabeled somatostatin analogs (SSAs), the presence of SSTRs on tumor cells may be …
radiolabeled somatostatin analogs (SSAs), the presence of SSTRs on tumor cells may be …
[HTML][HTML] THERANOSTICS: from molecular imaging using Ga-68 labeled tracers and PET/CT to personalized radionuclide therapy-the Bad Berka experience
RP Baum, HR Kulkarni - Theranostics, 2012 - ncbi.nlm.nih.gov
The acronym THERANOSTICS epitomizes the inseparability of diagnosis and therapy, the
pillars of medicine and takes into account personalized management of disease for a …
pillars of medicine and takes into account personalized management of disease for a …
The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair 86Y and 90Y
F Rösch, H Herzog, SM Qaim - Pharmaceuticals, 2017 - mdpi.com
In the context of radiopharmacy and molecular imaging, the concept of theranostics entails a
therapy-accompanying diagnosis with the aim of a patient-specific treatment. Using the …
therapy-accompanying diagnosis with the aim of a patient-specific treatment. Using the …
Past, present and future of 68Ge/68Ga generators
F Rösch - Applied Radiation and Isotopes, 2013 - Elsevier
68Ga represents one of the very early radionuclides applied to positron emission
tomography (PET) imaging at a time when even the wording PET itself was not established …
tomography (PET) imaging at a time when even the wording PET itself was not established …